Global Cord Blood (CO) Return on Equity ROE from the fourth quarter 2022 to fourth quarter 2021 and annually, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Global Cord Blood's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Global Cord Blood in the fourth quarter 2022?
Global Cord Blood Corp achieved a return on average equity (ROE) of 11.36 % in its fourth quarter 2022, this is above CO's average return on equity of 8.9%.
Global Cord Blood Corp shareholder's equity over the 12 months ending in its fourth quarter 2022 are valued at $708 million

ROE fell compared to the third quarter 2022, despite the net income growth of % from the third quarter 2022.

Within the Healthcare Facilities industry 19 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2022 from 0 to 1749.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2021)
IV. Quarter
Y / Y Equity Change 15.22 % 21.97 % 18.11 % 21.97 % -
Y / Y Net Income Change 2.01 % - - - 16.78 %
Net Income (TTM) in Millions 80 79 99 99 99
Return On Equity (TTM) 11.36 % 11.55 % 15.13 % 15.8 % 16.6 %
CO's Total Ranking # 1749 # 0 # 0 # 0 # 1216
Equity (TTM) in Millions 771 670 720 670 669
Seq. Equity Change 15.05 % -7.02 % 7.55 % 0.15 % 21.79 %
Seq. Net Income Change - - - - 296.16 %

Back to CO Management Effectiveness >> CO's 5 Years Annual ROE >> Compare CO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 20
Sector # 149
Overall # 1749

Return On Equity Statistics
High Average Low
12.31 %
8.9 %
5.34 %
(Mar 31 2020)   (Mar 31 2016)





CO Annual Return On Equity (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019		 (Mar 31 2018)
2018
Total Equity in Millions 770 669 548 509 496
Y / Y Equity Change 15.09 % 21.99 % 7.67 % 2.59 % 85.89 %
Net Income in Millions 80 79 67 44 38
Y / Y Net Income Change 2.01 % 16.78 % 53.38 % 14.54 % 105.4 %
Return On Equity 10.44 % 11.78 % 12.31 % 8.64 % 7.74 %

Back to CO Management Effectiveness >> CO's 5 Years Annual ROE >> Compare CO ROE to its Competitors




Annual Roe Comment
In 2022 ROE fell to 10.44 %, despite net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CO's' Return on Equity at Yahoo Finance
CO's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CO's Competitors
Subscribers only: Roe for Global Cord Blood's Suppliers
Subscribers only: Return On Equity for CO's Customers




Companies with similar Return On Equity at Mar 31 2022, within Healthcare Sector ROE
Quest Diagnostics Inc  31.07 %
West Pharmaceutical Services Inc   30.77 %
Select Medical Holdings Corp  30.41 %
Lftd Partners Inc   30.20 %
Harmony Biosciences Holdings inc   28.66 %
Zynex inc   28.38 %
Edwards Lifesciences Corporation  27.53 %
Johnson and Johnson  27.49 %
Incyte Corporation  27.21 %
Bruker Corporation  27.00 %
Lifevantage Corp  26.06 %
Resmed Inc   25.82 %
Antares Pharma Inc   25.74 %
Vertex Pharmaceuticals Inc  24.67 %
Agilent Technologies inc   24.23 %
Corcept Therapeutics Inc  24.23 %
Medpace Holdings Inc   24.17 %
Phibro Animal Health Corporation  24.07 %
Sotera Health Company  24.01 %
Sunlink Health Systems Inc   23.19 %
Progyny Inc   23.15 %
Catalyst Pharmaceuticals Inc   22.12 %
Abbott Laboratories  22.02 %
Carlisle Companies Incorporated  21.93 %
Gilead Sciences Inc   21.86 %
Jrsis Health Care Corp  21.77 %
Encompass Health Corporation  21.40 %
Labcorp Holdings Inc   20.13 %
Amedisys Inc  20.05 %
Align Technology inc   19.90 %

Date modified: 2026-09-18T16:03:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.